Leo Smit
CEO
Hy2Care
Hy2Care BV develops the CartRevive® hydrogel implant, which utilizes joint-tissue mimicking natural polymers to create a scaffold that supports the recovery of cartilage defects in joints. This technology addresses the need for effective healing of traumatic cartilage injuries, reducing pain and the risk of developing post-traumatic osteoarthritis.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$3.7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Traumatic cartilage defects resulting from injuries or accidents affect millions, causing pain and potentially leading to post-traumatic osteoarthritis. Current treatments often fail to provide sufficient long-term relief or facilitate complete cartilage regeneration.
Solution
Hy2Care BV's CartRevive® hydrogel implant is designed to promote functional recovery of cartilage defects in joints. The hydrogel, composed of joint-tissue mimicking natural polymers, acts as a scaffold to protect the injured site and facilitate natural tissue repair. By creating an environment conducive to cellular activity and matrix deposition, the implant supports the body's own healing mechanisms. This approach aims to alleviate pain, restore joint function, and reduce the risk of developing post-traumatic osteoarthritis.
Target Audience
The primary target audience includes individuals suffering from traumatic cartilage defects due to sports injuries, accidents, or falls, as well as healthcare professionals specializing in orthopedics and sports medicine.
Features
- Hydrogel composition mimics the natural environment of joint tissue.
- Provides a scaffold for cells to reside in and deposit new cartilage matrix.
- Supports the body's natural cartilage repair processes.
- Designed to protect the injured site during healing.